# Abbott Laboratories (ABT): SI in SEC Filings | SI Exposure

> Abbott Laboratories (ABT): 11.1% of its 10-K, 10-Q and 8-K filings in the last four quarters say "artificial intelligence". No "super intelligence" yet.

Source: https://tsio.si/exposure/abt/
Updated: 2026-11-11
Publisher: The SI Observatory (tsio.si), run by the SI community, built by Codeflex

1. [Home](https://tsio.si/)
2. [SI Exposure](https://tsio.si/exposure/)
3. Abbott Laboratories (ABT)

SI Exposure · Rank 74 of 100 · Health Care

# Abbott Laboratories (ABT) and SI

**2 of Abbott Laboratories's 18 10-K, 10-Q and 8-K filings in the last four full quarters (Q4 2025 to Q3 2026) contain "artificial intelligence" or the new name: 11.1%, rank 74 of the 100 largest US companies.** It has not used the new name, "super intelligence" or "superintelligence", in any SEC filing so far. Counts come from SEC EDGAR full text search, Nov 11, 2026.

Updated **Nov 11, 2026** · SEC CIK [1800](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000001800) · Sector **Health Care**

By quarter

[The full ranking](https://tsio.si/exposure/#ranking)

[Share on X](https://x.com/intent/post?text=Abbott+Laboratories+and+SI%3A+11.1%25+of+its+10-K%2C+10-Q+and+8-K+filings+now+contain+the+phrase%2C+rank+74+of+100.+From+SEC+EDGAR%3A&url=https%3A%2F%2Ftsio.si%2Fexposure%2Fabt%2F)

- **Share, last 4 quarters**: 11.1%
- **Filings with the phrase**: 2
- **New name, all time**: 0
- **Rank of 100**: 74

Over time

## Abbott Laboratories filings, quarter by quarter

Since Q1 2023: how many 10-K, 10-Q and 8-K filings Abbott Laboratories made each quarter and how many contain "artificial intelligence" or "super intelligence" or "superintelligence".

*Chart: Share of Abbott Laboratories 10-K, 10-Q and 8-K filings that contain either name. Per calendar quarter; Q4 2026 runs to Nov 11, 2026.*

| Quarter | Filings | Old name | New name | Share |
|---|---|---|---|---|
| Q4 2026 | 3 | 0 | 0 | 0.0% |
| Q3 2026 | 3 | 0 | 0 | 0.0% |
| Q2 2026 | 4 | 0 | 0 | 0.0% |
| Q1 2026 | 6 | 1 | 0 | 16.7% |
| Q4 2025 | 5 | 1 | 0 | 20.0% |
| Q3 2025 | 2 | 0 | 0 | 0.0% |
| Q2 2025 | 4 | 0 | 0 | 0.0% |
| Q1 2025 | 2 | 0 | 0 | 0.0% |
| Q4 2024 | 3 | 0 | 0 | 0.0% |
| Q3 2024 | 2 | 0 | 0 | 0.0% |
| Q2 2024 | 4 | 0 | 0 | 0.0% |
| Q1 2024 | 3 | 0 | 0 | 0.0% |
| Q4 2023 | 2 | 0 | 0 | 0.0% |
| Q3 2023 | 2 | 0 | 0 | 0.0% |
| Q2 2023 | 4 | 0 | 0 | 0.0% |
| Q1 2023 | 3 | 0 | 0 | 0.0% |

10-K, 10-Q and 8-K filings by calendar quarter. Old name: filings with "artificial intelligence". New name: filings with "super intelligence" or "superintelligence". A filing with both counts once in the share.

## Filings with the new name

None yet. When Abbott Laboratories first files a document with "super intelligence" or "superintelligence", it appears here with a link.

## Latest filings with "artificial intelligence"

1. Feb 20, 2026 [10-K](https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/abt-20251231.htm) 0001628280-26-010185
2. Nov 20, 2025 [8-K](https://www.sec.gov/Archives/edgar/data/1800/000110465925114422/tm2531676d2_ex2-1.htm) 0001104659-25-114422

Embed

## Put this card on any page

A plain image that links back here: no script, no cookies. It shows the latest build's numbers and its source. Free to use under CC BY 4.0.

Copy the embed

```
<a href="https://tsio.si/exposure/abt/"><img src="https://tsio.si/exposure/abt/card.svg" width="480" height="220" alt="SI Exposure of Abbott Laboratories: 11.1% of its 10-K, 10-Q and 8-K filings contain &quot;artificial intelligence&quot;"></a>
```

![SI Exposure card for Abbott Laboratories](https://tsio.si/exposure/abt/card.svg)

Compare

## Neighbors in the ranking and sector peers

[Rank 72 · Technology**NVIDIA Corporation**11.8% of filings · 0 with the new name](https://tsio.si/exposure/nvda/)

[Rank 73 · Technology**International Business Machines Corporation**11.8% of filings · 2 with the new name](https://tsio.si/exposure/ibm/)

[Rank 75 · Consumer Discretionary**TJX Companies Inc. (The)**10.0% of filings · 0 with the new name](https://tsio.si/exposure/tjx/)

[Rank 76 · Health Care**Merck & Company Inc.**9.1% of filings · 0 with the new name](https://tsio.si/exposure/mrk/)

[Rank 5 · Health Care**Eli Lilly and Company**72.7% of filings · 0 with the new name](https://tsio.si/exposure/lly/)

[Rank 7 · Health Care**Pfizer Inc.**71.4% of filings · 0 with the new name](https://tsio.si/exposure/pfe/)